Disclosure Of Entity's Operating Segments [Text Block]

BioInvent International - Filing #702054

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
19 384 SEK
147 372 SEK
Tax expense (income)
0 SEK
0 SEK
Profit (loss) before tax
278 444 SEK
76 333 SEK
Profit (loss)
278 444 SEK
278 444 SEK
76 333 SEK
76 333 SEK
Assets
1 447 311 SEK
802 640 SEK
Cash flows from (used in) operating activities
245 843 SEK
62 622 SEK
Cash flows from (used in) investing activities
467 542 SEK
6 700 SEK
Cash flows from (used in) financing activities
894 870 SEK
644 617 SEK
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.